Title : The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen - Henderson_2013_BMC.Neurol_13_188 |
Author(s) :
Henderson EJ , Lord SR , Close JC , Lawrence AD , Whone A , Ben-Shlomo Y |
Ref :
BMC Neurol , 13 :188 , 2013 |
Abstract : Henderson_2013_BMC.Neurol_13_188 |
ESTHER : Henderson_2013_BMC.Neurol_13_188 |
PubMedSearch : Henderson_2013_BMC.Neurol_13_188 |
PubMedID: 24299497 |